Without red teaming and hallucination review, organisations lose visibility into how AI systems fail under pressure. That can leave unsafe outputs, hidden prompt abuse, and unreliable decision support in production. The result is often weak control assurance, because teams discover issues only after users, customers, or downstream systems have already been affected.
Why This Matters for Security Teams
AI systems fail in ways that are easy to miss during normal testing and expensive to absorb after release. red teaming is what exposes adversarial prompts, unsafe tool use, policy bypasses, and brittle decision paths before those failures become operational incidents. Hallucination review matters for the same reason: output quality is not just a UX issue when people rely on AI for triage, drafting, access decisions, or customer responses.
Without adversarial testing, organisations often treat model output as if it were bounded by the same controls as traditional software. It is not. Current guidance from the NIST Cybersecurity Framework 2.0 stresses risk-aware validation and continuous monitoring, which aligns with how AI systems behave in practice. NHIMG’s analysis of secret exposure also shows how quickly weak control assumptions collapse once AI touches sensitive data, as seen in the State of Secrets in AppSec research.
The core issue is that untested AI does not fail loudly or consistently. It may appear reliable in demos, then produce unsafe, biased, or fabricated outputs under pressure. In practice, many security teams encounter the failure only after a user has already trusted the result and a downstream workflow has already acted on it.
How It Works in Practice
Red teaming should be treated as a pre-release and recurring control, not a one-time assurance exercise. The goal is to probe the system the way an attacker, a careless user, or a stressed business workflow would. That means testing prompt injection, jailbreak attempts, harmful tool chaining, data leakage, overconfident fabrication, and inconsistent behavior across repeated runs. Hallucination review then checks whether the model is producing unsupported claims, invented sources, or misleading confidence levels in the contexts that matter most.
For operational teams, the most useful approach is to combine adversarial testing with scenario-based review. Start with the highest-risk use cases, then validate model behavior against the actual prompts, tools, and data sources in production. Where AI systems invoke APIs or internal knowledge bases, review should include whether the model can be induced to reveal secrets, misstate policy, or escalate from harmless output into harmful action. This is especially important where output is consumed by analysts, developers, or customer-facing automation.
- Test for prompt injection and instruction override.
- Check whether the model fabricates facts, citations, or internal status.
- Validate safe refusal behavior for disallowed requests.
- Review tool access paths for unintended side effects.
- Track failures by use case, not just by model version.
Frameworks such as NIST CSF 2.0 and the NHIMG analysis in DeepSeek breach both reinforce the need to validate controls against real exposure paths, not vendor claims. These controls tend to break down when AI is connected to live business systems without clear test boundaries because failures then propagate into decisions, records, and customer interactions.
Common Variations and Edge Cases
Tighter red teaming often increases cost and delivery friction, requiring organisations to balance release speed against assurance depth. That tradeoff is real, but the risk profile changes sharply when AI is used for regulated advice, access workflows, incident support, or external communications. In those settings, shallow testing can be more expensive than a longer review cycle because errors become customer-visible or compliance-relevant.
Best practice is evolving on how much hallucination review is enough. There is no universal standard for this yet, so teams generally calibrate review depth to impact: low-risk drafting may need sampling, while high-impact decisions need structured evaluation, human sign-off, and defined rollback paths. The key is to avoid assuming that a model is “good enough” because it passed a narrow benchmark.
One important edge case is retrieval-augmented generation. RAG can reduce hallucinations, but it does not eliminate them, especially when retrieval is poor, context is stale, or the model is prompted to fill gaps with confidence. Another edge case is agentic workflows, where a single hallucinated step can trigger tool use, status changes, or secret exposure before a human sees the output. The practical question is not whether the model sounds plausible, but whether the surrounding control plane can detect and stop unsafe behavior before it matters.
Standards & Framework Alignment
This section maps relevant standards and security frameworks to the operational risks and controls described in this guidance.
OWASP Agentic AI Top 10, CSA MAESTRO and OWASP Non-Human Identity Top 10 address the attack and risk surface, while NIST AI RMF and NIST CSF 2.0 set the governance and control requirements practitioners need to meet.
| Framework | Control / Reference | Relevance |
|---|---|---|
| OWASP Agentic AI Top 10 | A03 | Covers prompt injection and unsafe tool use exposed by red teaming. |
| CSA MAESTRO | MA-04 | Addresses adversarial testing and control validation for agentic systems. |
| NIST AI RMF | Supports risk measurement, monitoring, and governance for AI failure modes. | |
| NIST CSF 2.0 | PR.DS | Relevant to protecting sensitive data from model leakage and unsafe disclosure. |
| OWASP Non-Human Identity Top 10 | NHI-05 | Red teaming often reveals secret exposure and credential misuse in AI workflows. |
Classify AI inputs and outputs, then apply controls that prevent sensitive data from leaking through prompts or responses.
Related resources from NHI Mgmt Group
- What breaks when organisations deploy AI agents without lifecycle governance?
- What breaks when organisations rely on one-time AI red teaming instead of continuous retesting?
- What breaks when organisations deploy AI models without clear guardrails for retrieval and output use?
- What breaks when pharma organisations deploy AI without clear lineage and consent tracking?